Total Payments
$196,219
2022 Payments
$1,097
Companies
19
Transactions
364
Medicare Patients
3,781
Medicare Billing
$631,660
Payment Breakdown by Category
Other$145,973 (74.4%)
Consulting$22,340 (11.4%)
Travel$20,140 (10.3%)
Food & Beverage$7,542 (3.8%)
Education$224.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $145,973 | 67 | 74.4% |
| Consulting Fee | $22,340 | 10 | 11.4% |
| Travel and Lodging | $20,140 | 95 | 10.3% |
| Food and Beverage | $7,542 | 181 | 3.8% |
| Education | $224.50 | 11 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $77,913 | 96 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41,146 | 53 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $32,429 | 88 | $0 (2019) |
| GlaxoSmithKline, LLC. | $16,371 | 50 | $0 (2019) |
| GENZYME CORPORATION | $8,637 | 11 | $0 (2021) |
| Genentech USA, Inc. | $6,864 | 14 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $6,272 | 9 | $0 (2018) |
| Philips Electronics North America Corporation | $3,484 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $1,773 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $602.39 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,097 | 5 | Janssen Pharmaceuticals, Inc ($940.00) |
| 2021 | $15,118 | 17 | Janssen Pharmaceuticals, Inc ($11,271) |
| 2020 | $18,700 | 21 | Janssen Pharmaceuticals, Inc ($10,387) |
| 2019 | $37,616 | 75 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14,634) |
| 2018 | $80,997 | 140 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22,974) |
| 2017 | $42,693 | 106 | Janssen Pharmaceuticals, Inc ($26,672) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Respiratory | ||||||
| 03/16/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Respiratory | ||||||
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Respiratory | ||||||
| 02/09/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $119.48 | General |
| Category: Respiratory | ||||||
| 01/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $886.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $359.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $6.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $367.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $5.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $94.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $116.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/27/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: Immunology | ||||||
| 07/20/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $886.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,069.00 | General |
| Category: Immunology | ||||||
| 11/19/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,132.00 | General |
| Category: Immunology | ||||||
| 11/18/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $849.00 | General |
| Category: Immunology | ||||||
| 10/15/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,132.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 296 | 360 | $39,145 | $17,354 |
| 2021 | 8 | 339 | 411 | $48,425 | $23,733 |
| 2020 | 19 | 3,146 | 6,771 | $950,290 | $590,572 |
Total Patients
3,781
Total Services
7,542
Medicare Billing
$631,660
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 125 | $24,792 | $11,575 | 46.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $9,242 | $3,814 | 41.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 23 | 24 | $1,512 | $587.82 | 38.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 47 | 51 | $1,173 | $472.53 | 40.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 43 | 45 | $1,080 | $352.65 | 32.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 48 | 52 | $884.00 | $348.46 | 39.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 28 | 32 | $462.00 | $202.85 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 134 | $25,518 | $13,533 | 53.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $11,250 | $5,083 | 45.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $5,375 | $2,631 | 48.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 29 | 30 | $1,890 | $782.41 | 41.4% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 52 | 57 | $1,459 | $588.44 | 40.3% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 54 | 59 | $1,171 | $486.89 | 41.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 52 | 54 | $1,384 | $450.93 | 32.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 20 | 22 | $378.00 | $178.12 | 47.1% |
| J0517 | Injection, benralizumab, 1 mg | Office | 2020 | 22 | 2,190 | $379,593 | $296,377 | 78.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 515 | 924 | $172,788 | $86,673 | 50.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 292 | 413 | $102,837 | $51,510 | 50.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 669 | 1,216 | $77,824 | $40,288 | 51.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 184 | 184 | $64,782 | $33,514 | 51.7% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 307 | 355 | $35,500 | $19,576 | 55.1% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 306 | 354 | $34,338 | $18,125 | 52.8% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2020 | 32 | 176 | $25,344 | $13,210 | 52.1% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 251 | 295 | $16,520 | $9,051 | 54.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 77 | 78 | $6,240 | $4,720 | 75.6% |
About Dr. James Lamberti, MD
Dr. James Lamberti, MD is a Pulmonary Disease healthcare provider based in Oakton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538175823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Lamberti, MD has received a total of $196,219 in payments from pharmaceutical and medical device companies, with $1,097 received in 2022. These payments were reported across 364 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($145,973).
As a Medicare-enrolled provider, Lamberti has provided services to 3,781 Medicare beneficiaries, totaling 7,542 services with total Medicare billing of $631,660. Data is available for 3 years (2020–2022), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Oakton, VA
- Active Since 07/31/2006
- Last Updated 02/05/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1538175823
Products in Payments
- XARELTO (Drug) $77,913
- UTIBRON (Drug) $25,713
- DUPIXENT (Biological) $10,379
- NUCALA (Biological) $7,995
- Xolair (Biological) $6,761
- LONHALA MAGNAIR (Drug) $6,681
- BEVYXXA (Drug) $6,272
- Other Resp ServSales (Device) $3,484
- STIOLTO RESPIMAT (Drug) $1,815
- EXPAREL (Drug) $300.00
- FASENRA (Drug) $159.79
- TEZSPIRE (Biological) $133.07
- Zemaira (Biological) $117.40
- OFEV (Drug) $101.65
- Esbriet (Biological) $88.22
- QVAR (Drug) $65.33
- BREO (Drug) $60.81
- BROVANA (Drug) $34.68
- SYMBICORT (Drug) $34.64
- Prolastin-C Liquid (Biological) $32.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.